NJ State Employees Deferred Compensation Plan’s Ironwood Pharmaceuticals IRWD Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,940	Closed	-$158K	–	476
2017 Q3	$158K	Sell	11,940 -35,820	-75%	-$493K	0.03%	441
2017 Q2	$755K	Hold	47,760	–	–	0.14%	218
2017 Q1	$682K	Hold	47,760	–	–	0.13%	237
2016 Q4	$612K	Hold	47,760	–	–	0.12%	253
2016 Q3	$635K	Hold	47,760	–	–	0.13%	238
2016 Q2	$523K	Hold	47,760	–	–	0.11%	265
2016 Q1	$470K	Hold	47,760	–	–	0.1%	271
2015 Q4	$464K	Hold	47,760	–	–	0.1%	284
2015 Q3	$417K	Hold	47,760	–	–	0.09%	294
2015 Q2	$482K	Hold	47,760	–	–	0.09%	289
2015 Q1	$640K	Hold	47,760	–	–	0.12%	264
2014 Q4	$613K	Hold	47,760	–	–	0.12%	268
2014 Q3	$518K	Hold	47,760	–	–	0.11%	287
2014 Q2	$613K	Hold	47,760	–	–	0.12%	279
2014 Q1	$493K	Hold	47,760	–	–	0.1%	299
2013 Q4	$464K	Hold	47,760	–	–	0.09%	309
2013 Q3	$474K	Hold	47,760	–	–	0.1%	301
2013 Q2	$397K	Buy	+47,760	New	+$579K	0.09%	316

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's IRWD Position: Q4 2017 in Review

NJ State Employees Deferred Compensation Plan sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2017, closing a stake of 11,940 shares — an estimated $158K sold.

NJ State Employees Deferred Compensation Plan first reported a position in IRWD in Q2 2013 and held it in 18 quarters. The position peaked at $755K in Q2 2017. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

NJ State Employees Deferred Compensation Plan reported no remaining Ironwood Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 11,940 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $158K.
NJ State Employees Deferred Compensation Plan first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 18 quarters.
NJ State Employees Deferred Compensation Plan's Ironwood Pharmaceuticals position peaked at $755K in Q2 2017.
158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2017, filed 6 Feb 2018.